Home » Topics » Medical technology » Diagnostics

Diagnostics
RSS

PET/CT tracer anti-3-[18F]-FACBC effectively detects recurrent prostate cancer

July 1, 2010

Phase II data support use of florbetaben to diagnose AD using PET

June 23, 2010

Bayer Schering claims new imaging agents to monitor tumors

June 23, 2010

GE Healthcare identifies novel contrast agents for X-ray-based diagnosis

June 17, 2010

FDA grants marketing clearance for Xpert SA Nasal Complete

June 11, 2010

FDA approves Roche Diagnostics' Elecsys anti-HCV assay

June 7, 2010

FDA approves Photocure's Cysview for bladder cancer detection

June 1, 2010

Diagnostic/prognostic gene expression signature identified for UCC

June 1, 2010

FDA and EMA approve reanalysis of images from phase III RG-1068 trial

May 31, 2010

FDA clears Simplexa influenza A H1N1 (2009) test

May 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...